NWF Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59K Hold
104,139
0.01% 400
2025
Q4
$66.6K Hold
104,139
0.01% 398
2025
Q3
$97.3K Hold
104,139
0.01% 399
2025
Q2
$133K Hold
104,139
0.02% 391
2025
Q1
$104K Buy
+104,139
New +$110K 0.01% 347
2024
Q4
Sell
-66,800
Closed -$100K 311
2024
Q3
$100K Buy
66,800
+10,000
+18% +$11K 0.01% 328
2024
Q2
$39.9K Hold
56,800
0.01% 312
2024
Q1
$54K Buy
56,800
+2,100
+4% +$2.04K 0.01% 320
2023
Q4
$60.7K Buy
54,700
+6,250
+13% +$9.28K 0.01% 287
2023
Q3
$91.1K Buy
48,450
+4,000
+9% +$11.5K 0.02% 274
2023
Q2
$160K Hold
44,450
0.04% 248
2023
Q1
$160K Buy
+44,450
New +$133K 0.04% 247

Other funds holding CTSO

NWF Advisory Services's CTSO Position: Q1 2026 in Review

NWF Advisory Services held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 104,139 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #400.

NWF Advisory Services first reported a position in CTSO in Q1 2023 and has held it in 12 quarters since. The position peaked at $160K in Q2 2023. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • NWF Advisory Services held 104,139 shares of Cytosorbents Corp worth $59K as of Q1 2026.
  • NWF Advisory Services left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up 0.01% of NWF Advisory Services's portfolio in Q1 2026, its #400 holding.
  • NWF Advisory Services first reported a position in Cytosorbents Corp in Q1 2023 and has held it in 12 quarters since.
  • NWF Advisory Services's Cytosorbents Corp position peaked at $160K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.